Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10556961 Anti-CD38 antibodies for treatment of acute lymphoblastic leukemia

Patent 10556961 was granted and assigned to Janssen Biotech on February, 2020 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

Currently, there are no issues on this topic.

Find more entities like US Patent 10556961 Anti-CD38 antibodies for treatment of acute lymphoblastic leukemia

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo